Related Experiment Video
Updated: Jun 19, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Management of JIA associated uveitis
Ilaria Maccora1, Gabriele Simonini1, Catherine M Guly2
1NeuroFARBA Department, University of Florence, Florence, Italy; Rheumatology Unit, ERN ReCONNET Center, Meyer Children's Hospital IRCCS, Florence, Italy.
Early screening and multidisciplinary management are crucial for childhood Juvenile Idiopathic Arthritis (JIA) associated uveitis. Treatment typically involves a step-wise approach, starting with methotrexate and potentially adalimumab, to prevent vision loss.
Area of Science:
- Pediatric Rheumatology
- Ophthalmology
- Immunology
Background:
- Juvenile Idiopathic Arthritis (JIA) is a common childhood rheumatic disease.
- Uveitis affects up to 25% of JIA patients, often being chronic and asymptomatic.
- Early detection and treatment of JIA-associated uveitis are vital to prevent sight-threatening complications.
Purpose of the Study:
- To outline the importance of screening for uveitis in JIA patients.
- To describe the recommended multidisciplinary management approach for JIA-associated uveitis.
- To review current treatment strategies and emerging therapeutic options.
Main Methods:
- Literature review of current international recommendations and treatment guidelines.
- Emphasis on the collaborative role of pediatric rheumatologists and ophthalmologists.
- Discussion of step-wise treatment protocols and alternative therapies.
Main Results:
- Screening for uveitis is essential in JIA management.
- A collaborative, multidisciplinary approach is key for effective treatment.
- Methotrexate is the first-line therapy, with adalimumab as a common second-line option.
Conclusions:
- Prompt diagnosis and management of JIA-associated uveitis can prevent severe ocular complications.
- Adherence to step-wise treatment protocols, including methotrexate and adalimumab, is recommended.
- Further research is needed for alternative therapies like anti-IL6 or other anti-TNF agents in refractory cases.
Related Concept Videos
Tonsillitis II: Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

